1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Aeglea BioTherapeutics, Inc.US flagNASDAQ Global Market
12.01
USD
+0.75
- -
48.63MMarket Cap

Total Valuation

Aeglea BioTherapeutics, Inc. carries a market capitalization of 48.63M, placing it among publicly traded companies globally.

Market Cap48.63M
Enterprise ValueN/A

Stock Price Statistics

Aeglea BioTherapeutics, Inc.'s stock has gained approximately 23.81443% over the past 52 weeks. The 50-day moving average sits at 12.64, while the 200-day moving average is 9.84.

Beta (5Y)N/A
52-Week Price Change23.81443%
50-Day Moving Average12.64
200-Day Moving Average9.84
Average Volume (20 Days)N/A

Stock Splits

Aeglea BioTherapeutics, Inc.'s most recent stock split took place on September 8, 2023 with a 25:1 split ratio.

Last Split Date9/8/2023
Split Ratio25:1